TW200631609A - Enteric coated bead comprising ixabepilone, and preparation and administration thereof - Google Patents
Enteric coated bead comprising ixabepilone, and preparation and administration thereofInfo
- Publication number
- TW200631609A TW200631609A TW094140483A TW94140483A TW200631609A TW 200631609 A TW200631609 A TW 200631609A TW 094140483 A TW094140483 A TW 094140483A TW 94140483 A TW94140483 A TW 94140483A TW 200631609 A TW200631609 A TW 200631609A
- Authority
- TW
- Taiwan
- Prior art keywords
- enteric coated
- ixabepilone
- coated bead
- administration
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62897004P | 2004-11-18 | 2004-11-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200631609A true TW200631609A (en) | 2006-09-16 |
Family
ID=35976527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094140483A TW200631609A (en) | 2004-11-18 | 2005-11-17 | Enteric coated bead comprising ixabepilone, and preparation and administration thereof |
Country Status (26)
Country | Link |
---|---|
US (1) | US20060153917A1 (zh) |
EP (2) | EP1817013B1 (zh) |
JP (1) | JP2008520696A (zh) |
KR (1) | KR20070084325A (zh) |
CN (1) | CN101083978A (zh) |
AR (1) | AR052142A1 (zh) |
AT (1) | ATE397442T1 (zh) |
AU (1) | AU2005306464A1 (zh) |
BR (1) | BRPI0518286A2 (zh) |
CA (1) | CA2588400A1 (zh) |
DE (1) | DE602005007376D1 (zh) |
DK (1) | DK1817013T3 (zh) |
ES (1) | ES2306278T3 (zh) |
HK (1) | HK1106713A1 (zh) |
HR (1) | HRP20080349T3 (zh) |
IL (1) | IL183116A0 (zh) |
MX (1) | MX2007005763A (zh) |
NO (1) | NO20072388L (zh) |
PE (1) | PE20061058A1 (zh) |
PL (1) | PL1817013T3 (zh) |
PT (1) | PT1817013E (zh) |
RU (1) | RU2349319C1 (zh) |
SI (1) | SI1817013T1 (zh) |
TW (1) | TW200631609A (zh) |
WO (1) | WO2006055740A1 (zh) |
ZA (1) | ZA200703955B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101091725A (zh) | 2006-06-23 | 2007-12-26 | 天津天士力制药股份有限公司 | 一种中药颗粒及其制备方法 |
US20110217426A1 (en) * | 2010-03-04 | 2011-09-08 | Perry Stephen C | Enteric coating composition |
LT3117709T (lt) | 2010-03-12 | 2018-11-26 | Genzyme Corporation | Kombinuota terapija krūties vėžio gydymui |
WO2012047802A2 (en) * | 2010-10-01 | 2012-04-12 | The Johns Hopkins University | Systems and methods for high-throughput microfluidic bead production |
US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
CN103442727B (zh) | 2011-02-11 | 2016-08-10 | Zx制药有限责任公司 | 多微粒l-薄荷醇制剂及相关方法 |
US8911780B2 (en) | 2011-02-11 | 2014-12-16 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
RS58325B1 (sr) | 2013-04-23 | 2019-03-29 | Zx Pharma Llc | Enterosolventno obloženi višečestični preparat sa proteinskom sub-oblogom |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4713246A (en) * | 1984-03-19 | 1987-12-15 | Bristol-Myers Company | Etoposide oral dosage form |
US6537579B1 (en) * | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
JP4183099B2 (ja) * | 1995-11-17 | 2008-11-19 | ゲゼルシャフト・フュア・ビオテヒノロジッシェ・フォルシュング・ミット・ベシュレンクテル・ハフツング(ゲー・ベー・エフ) | エポチロンcおよびd、製造法ならびに組成物 |
JP4090529B2 (ja) * | 1996-01-24 | 2008-05-28 | フロイント産業株式会社 | 乳糖の球形粒及びその製造方法 |
US6011029A (en) | 1996-02-26 | 2000-01-04 | Bristol-Myers Squibb Company | Inhibitors of farnesyl protein transferase |
DE69732780T2 (de) * | 1996-10-02 | 2006-04-06 | Novartis Ag | Pyrimiderivate und verfahren zu ihrer herstellung |
CN100344627C (zh) * | 1996-11-18 | 2007-10-24 | 生物技术研究有限公司(Gbf) | 埃坡霉素c、其制备方法以及作为细胞抑制剂和植物保护剂的应用 |
FR2759293B1 (fr) * | 1997-02-11 | 1999-04-30 | Ethypharm Lab Prod Ethiques | Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie |
CZ298027B6 (cs) * | 1997-02-25 | 2007-05-30 | Gesellschaft Fuer Biotechnologische Forschung Mbh(Gbf) | Zpusob prípravy epothilon-N-oxidu a N-oxidy epothilonu |
GB9801231D0 (en) | 1997-06-05 | 1998-03-18 | Merck & Co Inc | A method of treating cancer |
US6605599B1 (en) | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
US6040321A (en) | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
US6365749B1 (en) | 1997-12-04 | 2002-04-02 | Bristol-Myers Squibb Company | Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
FR2775187B1 (fr) * | 1998-02-25 | 2003-02-21 | Novartis Ag | Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo |
US6399638B1 (en) * | 1998-04-21 | 2002-06-04 | Bristol-Myers Squibb Company | 12,13-modified epothilone derivatives |
US6498257B1 (en) * | 1998-04-21 | 2002-12-24 | Bristol-Myers Squibb Company | 2,3-olefinic epothilone derivatives |
UA69413C2 (uk) * | 1998-05-22 | 2004-09-15 | Брістол-Майерс Сквібб Компані | Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції |
US7122207B2 (en) * | 1998-05-22 | 2006-10-17 | Bristol-Myers Squibb Company | High drug load acid labile pharmaceutical composition |
DE19826988A1 (de) * | 1998-06-18 | 1999-12-23 | Biotechnolog Forschung Gmbh | Epothilon-Nebenkomponenten |
UA73092C2 (uk) * | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
US5997905A (en) * | 1998-09-04 | 1999-12-07 | Mcneil-Ppc | Preparation of pharmaceutically active particles |
NZ510928A (en) * | 1998-10-01 | 2002-10-25 | Powderject Res Ltd | Spray coated powder composition formed from seed particles between 10-100 micrometres coated with an aqueous pharmaceutical composition |
KR100718616B1 (ko) * | 1999-02-18 | 2007-05-16 | 바이엘 쉐링 파마 악티엔게젤샤프트 | 16-할로겐-에포틸론 유도체, 그 제조 방법 및 제약학적 용도 |
NZ513629A (en) * | 1999-02-22 | 2004-01-30 | Bristol Myers Squibb Co | C-21 modified epothilones |
US6518421B1 (en) * | 2000-03-20 | 2003-02-11 | Bristol-Myers Squibb Company | Process for the preparation of epothilone analogs |
BR0107147A (pt) * | 2000-08-09 | 2002-06-18 | Panacea Biotec Ltd | Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações |
UA75365C2 (en) | 2000-08-16 | 2006-04-17 | Bristol Myers Squibb Co | Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon |
KR20030069993A (ko) * | 2000-09-22 | 2003-08-27 | 게젤샤프트 퓌어 비오테크놀로기쉐 포르슝 엠베하(게베에프) | 트리아졸로-에포틸론 |
ATE279552T1 (de) | 2000-09-26 | 2004-10-15 | Enthone Omi Deutschland Gmbh | Verfahren zur selektiven metallisierung dielektrischer materialien |
WO2002058699A1 (en) * | 2001-01-25 | 2002-08-01 | Bristol-Myers Squibb Company | Pharmaceutical forms of epothilones for oral administration |
HU229349B1 (en) * | 2001-01-25 | 2013-11-28 | Bristol Myers Squibb Co | Methods for preparation of pharmaceutical composition containing epothilone analogs useful for treatment of cancer |
EP1353667A1 (en) * | 2001-01-25 | 2003-10-22 | Bristol-Myers Squibb Company | Parenteral formulations containing epothilone analogs |
CN1774253A (zh) * | 2001-02-20 | 2006-05-17 | 布里斯托尔-迈尔斯斯奎布公司 | 用环氧丙酯酮衍生物治疗顽固性肿瘤 |
EE200300397A (et) * | 2001-02-20 | 2003-12-15 | Bristol-Myers Squibb Company | Epotilooni derivaadid refraktaarsete kasvajate raviks |
US7312237B2 (en) * | 2001-03-14 | 2007-12-25 | Bristol-Myers Squibb Co. | Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases |
WO2002098868A1 (en) * | 2001-06-01 | 2002-12-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
JP4645789B2 (ja) * | 2001-06-18 | 2011-03-09 | Jsr株式会社 | ネガ型感放射線性樹脂組成物 |
ES2337134T3 (es) * | 2002-03-12 | 2010-04-21 | Bristol-Myers Squibb Company | Derivados de c3-ciano-epotilona. |
AU2003218107A1 (en) * | 2002-03-12 | 2003-09-29 | Bristol-Myers Squibb Company | C12-cyano epothilone derivatives |
TW200403994A (en) * | 2002-04-04 | 2004-03-16 | Bristol Myers Squibb Co | Oral administration of EPOTHILONES |
TW200400191A (en) * | 2002-05-15 | 2004-01-01 | Bristol Myers Squibb Co | Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives |
AU2003243561A1 (en) | 2002-06-14 | 2003-12-31 | Bristol-Myers Squibb Company | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
AU2003256157A1 (en) * | 2002-08-05 | 2004-02-23 | Dsm Ip Assets B.V. | Oral dosage forms of water insoluble drugs and methods of making the same |
AU2003279911A1 (en) * | 2002-10-09 | 2004-05-04 | Kosan Biosciences, Inc. | Therapeutic formulations |
US20050171167A1 (en) * | 2003-11-04 | 2005-08-04 | Haby Thomas A. | Process and formulation containing epothilones and analogs thereof |
WO2006055742A1 (en) * | 2004-11-18 | 2006-05-26 | Bristol-Myers Squibb Company | Enteric coated bead comprising epothilone or epothilone analog, and preparation and administration thereof |
-
2005
- 2005-11-17 KR KR1020077011236A patent/KR20070084325A/ko not_active Application Discontinuation
- 2005-11-17 EP EP05824194A patent/EP1817013B1/en active Active
- 2005-11-17 DE DE602005007376T patent/DE602005007376D1/de not_active Expired - Fee Related
- 2005-11-17 TW TW094140483A patent/TW200631609A/zh unknown
- 2005-11-17 BR BRPI0518286-7A patent/BRPI0518286A2/pt not_active IP Right Cessation
- 2005-11-17 CN CNA2005800393851A patent/CN101083978A/zh active Pending
- 2005-11-17 PE PE2005001348A patent/PE20061058A1/es not_active Application Discontinuation
- 2005-11-17 PL PL05824194T patent/PL1817013T3/pl unknown
- 2005-11-17 AU AU2005306464A patent/AU2005306464A1/en not_active Abandoned
- 2005-11-17 SI SI200530318T patent/SI1817013T1/sl unknown
- 2005-11-17 PT PT05824194T patent/PT1817013E/pt unknown
- 2005-11-17 JP JP2007543252A patent/JP2008520696A/ja not_active Withdrawn
- 2005-11-17 EP EP08008815A patent/EP1958625A1/en not_active Withdrawn
- 2005-11-17 CA CA002588400A patent/CA2588400A1/en not_active Abandoned
- 2005-11-17 RU RU2007122627/15A patent/RU2349319C1/ru not_active IP Right Cessation
- 2005-11-17 ES ES05824194T patent/ES2306278T3/es active Active
- 2005-11-17 AR ARP050104839A patent/AR052142A1/es unknown
- 2005-11-17 AT AT05824194T patent/ATE397442T1/de not_active IP Right Cessation
- 2005-11-17 WO PCT/US2005/041736 patent/WO2006055740A1/en active Application Filing
- 2005-11-17 MX MX2007005763A patent/MX2007005763A/es active IP Right Grant
- 2005-11-17 US US11/281,855 patent/US20060153917A1/en not_active Abandoned
- 2005-11-17 DK DK05824194T patent/DK1817013T3/da active
-
2007
- 2007-05-09 NO NO20072388A patent/NO20072388L/no not_active Application Discontinuation
- 2007-05-10 IL IL183116A patent/IL183116A0/en unknown
- 2007-05-16 ZA ZA200703955A patent/ZA200703955B/xx unknown
-
2008
- 2008-01-10 HK HK08100342A patent/HK1106713A1/xx not_active IP Right Cessation
- 2008-07-31 HR HR20080349T patent/HRP20080349T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL183116A0 (en) | 2007-09-20 |
RU2349319C1 (ru) | 2009-03-20 |
US20060153917A1 (en) | 2006-07-13 |
AU2005306464A1 (en) | 2006-05-26 |
CN101083978A (zh) | 2007-12-05 |
NO20072388L (no) | 2007-06-14 |
WO2006055740A1 (en) | 2006-05-26 |
PL1817013T3 (pl) | 2009-01-30 |
EP1817013A1 (en) | 2007-08-15 |
PT1817013E (pt) | 2008-08-07 |
PE20061058A1 (es) | 2006-10-13 |
CA2588400A1 (en) | 2006-05-26 |
BRPI0518286A2 (pt) | 2008-11-11 |
JP2008520696A (ja) | 2008-06-19 |
ES2306278T3 (es) | 2008-11-01 |
AR052142A1 (es) | 2007-03-07 |
HK1106713A1 (en) | 2008-03-20 |
SI1817013T1 (sl) | 2008-12-31 |
MX2007005763A (es) | 2007-07-20 |
EP1817013B1 (en) | 2008-06-04 |
DE602005007376D1 (de) | 2008-07-17 |
HRP20080349T3 (en) | 2009-01-31 |
EP1958625A1 (en) | 2008-08-20 |
KR20070084325A (ko) | 2007-08-24 |
ZA200703955B (en) | 2008-08-27 |
DK1817013T3 (da) | 2008-10-13 |
ATE397442T1 (de) | 2008-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200631609A (en) | Enteric coated bead comprising ixabepilone, and preparation and administration thereof | |
JO2464B1 (en) | Formulas contain actinacidine and binary sugars | |
IL210378A0 (en) | Tumor associated antigen, peptides thereof, and use of same as ati-tumor vaccines | |
WO2002097395A3 (en) | P-cadherin as a target for anti-cancer therapy | |
AU2003232330A1 (en) | Method of preparing microparticles | |
WO2007024705A3 (en) | Method of treating depression using a tnf-alpha antibody | |
AU2002328945A1 (en) | Methods for improved treatment of cancer with irinotecan based on mrp1 | |
AU2003271021A1 (en) | Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof | |
GB2402402B (en) | Substrate for immobilizing physiological material, and a method of preparing the same | |
WO2006048864A3 (en) | Sterile preparations and compositions including stinging capsules and methods of producing and using same | |
WO2006105255A3 (en) | Cancer vaccines and therapeutic methods | |
EP1534512A4 (en) | COATED PARTICLES, MANUFACTURING AND USE METHOD | |
AU2003278175A1 (en) | Vaccines of enhanced immunogenicity, and methods for preparing such vaccines | |
EP1701718A4 (en) | SUBSTITUTED MELATONIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND METHOD OF ADMINISTRATION | |
PL359208A1 (en) | New derivatives of quinosoline, method of production of new derivatives of quinosoline and pharmaceutical preparations | |
AU2002233407A1 (en) | 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof | |
AU2000279747A1 (en) | Emulsion of perfluororganic compounds for medical purposes, method for producingsaid emulsion and methods for curing and preventing diseases with the aid of the emulsion | |
AU2003272086A1 (en) | Enteric coated pellets comprising esomeprazole, hard gelatin capsule containing them, and method of preparation | |
WO2004106379A8 (en) | Immunotherapy of rectal cancer | |
AU2003264319A1 (en) | New tumor antigen vaccine and producing method and vaccine composition | |
EP1711619A4 (en) | INTEGRATED VIRUS COMPLEXES, METHOD FOR THE MANUFACTURE THEREOF, VACCINES CONTAINING THEM AND METHOD FOR THE USE THEREOF | |
AU2003268180A1 (en) | Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix | |
IL172482A0 (en) | Process for the preparation of insulin sensitizer and intermediate compound thereof | |
AU2002365104A1 (en) | Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof | |
AU2003303815A1 (en) | Alanines compounds, method of preparing them and their use |